| Title | Author(s) | Year | View Count |  | A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial | Lui, SL; Yung, S; Yim, A; Wong, KM; Tong, KL; Wong, KS; Li, CS; Au, TC; Lo, WK; Ho, YW; Ng, F; Tang, C; Chan, TM | 2012 | 114 |
| Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide | Mok, CC; Ying, KY; Ng, WL; Lee, KW; To, CH; Lau, CS; Wong, RWS; Au, TC | 2006 | 65 |
| Treatment of Pure Membranous Lupus Nephropathy with Prednisone and Azathioprine: An Open-Label Trial | Mok, CC; Ying, KY; Lau, CS; Yim, CW; Ng, WL; Wong, WS; Au, TC | 2004 | 61 |
 | CUHK Molecular SARS Research Group. Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong | Chim, SS; Tsui, SK; Chan, KC; Au, TC; Hung, EC; Tong, YK; Chiu, RW; Ng, EK; Chan, PK; Chu, CM; Sung, JJ; Tam, JS; Fung, KP; Waye, MM; Lee, CY; Yuen, KY; Lo, YM | 2003 | 131 |
| Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens | Mok, CC; Ho, CTK; Siu, YP; Chan, KW; Kwan, TH; Lau, WCS; Wong, RWS; Au, TC | 2001 | 113 |
| Daily and nocturnal hemodialysis: How do they stack up? | Mok, CC; Ho, CTK; Siu, YP; Chan, KW; Kwan, TH; Lau, CS; Wong, RWS; Au, TC | 2001 | 55 |
|
